Garden Cress Seed Extracts Show Strongest Inhibition Against Bacterial Isolates

A preprint on Lepidium sativum seed extracts points to measurable antimicrobial activity across four test organisms, with the clearest signal seen against bacteria rather than fungi. Methanol outperformed acetone in nearly every comparison, a pattern that fits the chemistry of plant extraction: more polar solvents often draw out a broader mix of phenolic compounds, alkaloids, flavonoids, and other secondary metabolites with membrane-active or enzyme-inhibitory effects.

The study tested extracts against Staphylococcus aureus, Escherichia coli, Candida albicans, and Fusarium oxysporum. Zone-of-inhibition data showed the largest effect against S. aureus, where the methanol extract reached 23.6 mm and the acetone extract 22.9 mm. E. coli followed with 21.5 mm for methanol and 18.3 mm for acetone. In the fungal isolates, activity remained present but clearly weaker: C. albicans measured 16.2 mm and 14.8 mm, while F. oxysporum showed the smallest zones at 12.4 mm and 10.7 mm.

One pattern stands out immediately. Gram-positive bacteria were inhibited more strongly than the fungal isolates.

Solvent Choice Shaped the Antimicrobial Signal

The solvent comparison matters because it provides a clue to which chemical families are doing the work. Methanol generally extracts a wider range of bioactive constituents than acetone, and the larger inhibition zones in the methanol arm suggest that the most potent compounds in garden cress seed may be more efficiently recovered in a polar solvent system. In practical terms, the result does not simply say the plant works; it says extraction conditions can determine how much of that activity becomes measurable in the laboratory.

That difference appeared in both the bacterial and fungal panels. Methanol exceeded acetone for S. aureus, E. coli, C. albicans, and F. oxysporum, although the gap was most clinically compelling in the bacteria. For antimicrobial screening, such a pattern often raises the possibility of cell-wall or membrane disruption, a mechanism that tends to affect bacterial physiology more readily than the more complex fungal envelope. The preprint does not identify the exact phytochemicals responsible, but the direction of effect is consistent with a plant extract rich in compounds capable of damaging microbial membranes or interfering with metabolic pathways.

Minimum Inhibitory Concentrations Favored the Methanol Extract

The minimum inhibitory concentration findings reinforced the same hierarchy. MIC values ranged from 10−1 to 10−4 dilutions, and the methanol extract maintained higher efficacy at lower concentrations. In laboratory terms, that suggests a more sustained antimicrobial effect as the extract was diluted, rather than a sharp drop-off after the most concentrated preparations.

This matters because dilution-based results are often where crude extracts either prove their value or collapse under pressure. A strong zone of inhibition can sometimes overstate performance if the active compounds are concentrated only at the surface of the agar. MIC data help test whether the effect persists when exposure drops. Here, the methanol preparation remained the stronger of the two solvent-derived extracts, making the antimicrobial signal more credible than a single diffusion result would have on its own.

The activity against S. aureus was especially notable. Gram-positive organisms are often more vulnerable to plant-derived compounds because their cell wall architecture differs from that of gram-negative bacteria, which carry an outer membrane that can restrict compound entry. E. coli still showed inhibition, but the lower acetone effect suggests that not all extracts penetrate or destabilize bacterial defenses equally.

Fungal Inhibition Was Present but Less Robust

Fungal susceptibility trailed bacterial susceptibility throughout the dataset. C. albicans showed moderate inhibition, while F. oxysporum responded least strongly. That distribution is not surprising in crude extract studies, since fungal cell structures can be harder to disrupt and may require compounds with more specific antifungal activity than those that primarily affect bacteria.

Even so, the presence of measurable antifungal zones matters. It suggests the seed extract is not narrowly antibacterial, but rather contains a mixture of molecules with broader antimicrobial potential. In a pharmacologic sense, that widens the interest around Lepidium sativum as a candidate source for fractionation, purification, and mechanism-focused follow-up work. A crude plant extract is not a drug candidate by itself, yet it can serve as a starting point for isolating a more defined active fraction.

What This Preprint Adds to Plant-Derived Antimicrobial Research

The work strengthens a familiar but still useful premise: edible or medicinal plants can harbor compounds with genuine inhibitory activity against common human pathogens. Garden cress has long been discussed in traditional and nutritional contexts, and this preprint pushes it into a microbiology frame by pairing solvent extraction with direct antimicrobial testing. The data support a biologically plausible interpretation: the seed contains extractable compounds that can suppress microbial growth under in vitro conditions.

At the same time, the findings remain early-stage. The article presents laboratory inhibition data, not clinical outcomes, and no human safety, pharmacokinetic, or toxicity data are included. Without those steps, no responsible reader should equate a larger zone of inhibition with therapeutic readiness. Plant extracts can be promising in vitro and still fail in the body because of poor absorption, rapid metabolism, instability, or unacceptable toxicity.

Even within the confines of the study, the hierarchy is clear: methanol extraction produced the stronger antimicrobial profile, S. aureus responded best, and F. oxysporum was least affected. Those are the most concrete signals available from the preprint, and they point toward further phytochemical characterization rather than immediate clinical application.

The publication record here also matters. bioRxiv labels the work as a preprint, which means the findings have not yet undergone peer review. For antimicrobial screening studies, that leaves open important questions about reproducibility, standardization of extract preparation, and whether the reported effects persist across independent batches of seed material. The next useful step is not exaggeration; it is isolation of the active constituents, comparison with standard antimicrobials, and testing under more rigorous experimental conditions.


Reporting by Dr. A. Nikhil Krishnan, MBBS for Medicine World Foundation, with additional data provided by bioRxiv (Biomedical Preprints).
PRIMARY CLINICAL EVIDENCE & REGISTRY DATA